Tokyo, Japan – December 17, 2019 – LPIXEL Inc., a leader in image analysis and processing in life science and medical research, is pleased to announce that it has been selected to participate in “X-HUB TOKYO ~ GLOBAL STARTUP ACCELERATOR Batch 2: Healthcare Batch.” X-HUB TOKYO GLOBAL STARTUP ACCELERATOR, the global accelerator program organized by the Tokyo Metropolitan Government, is intended to accelerate the growth and support of Tokyo-based startups by helping them establish partnerships with global companies that have channels around the world. Throughout the program, participating startups will be provided with pitching and business training support. Boston Scientific Corporation will be the cooperation partner for this round of the program.
Following “X-HUB Tokyo: Germany, Berlin Munich,” this will be the second time for LPIXEL to participate in the program. LPIXEL plans to leverage the support from this program to accelerate the global business expansion of LPIXEL’S medical image AI, EIRL. More details here.
LPIXEL is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPIXEL is dedicated to offering research facilities top-tier image analysis technologies and medical diagnosis technologies, both of which adopt advanced AI technology. The company is currently working in collaboration with the University of Tokyo Hospital, the National Cancer Center Japan and other research institutions to further the development of its AI-based medical diagnosis technology. For more information, please visit https://lpixel.net/en/.